Detalhe da pesquisa
1.
No evidence of extensive non-CpG methylation in mtDNA.
Nucleic Acids Res
; 50(16): 9190-9194, 2022 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35979955
2.
DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease.
Mov Disord
; 38(11): 2064-2071, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37551021
3.
Advancing nutrition science to meet evolving global health needs.
Eur J Nutr
; 62(Suppl 1): 1-16, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38015211
4.
Differential transcript usage in the Parkinson's disease brain.
PLoS Genet
; 16(11): e1009182, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33137089
5.
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Mov Disord
; 37(5): 1016-1027, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35106798
6.
Correction: The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations.
Genet Med
; 21(4): 1027, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30228318
7.
Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients.
J Med Genet
; 55(1): 21-27, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29101127
8.
Movement disorders in mitochondrial disease: a clinicopathological correlation.
Curr Opin Neurol
; 31(4): 472-483, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29750731
9.
Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Acta Neuropathol
; 135(3): 409-425, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29270838
10.
Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
Mov Disord
; 33(10): 1591-1600, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30256453
11.
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
Alzheimers Dement
; 14(10): 1293-1301, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29792872
12.
The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations.
Genet Med
; 19(11): 1217-1225, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28471437
13.
Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia.
Mov Disord
; 32(2): 241-245, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27862270
14.
Glitazone use associated with reduced risk of Parkinson's disease.
Mov Disord
; 32(11): 1594-1599, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28861893
15.
The presence of anaemia negatively influences survival in patients with POLG disease.
J Inherit Metab Dis
; 40(6): 861-866, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28865037
16.
Understanding the Epilepsy in POLG Related Disease.
Int J Mol Sci
; 18(9)2017 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28837072
17.
[Multiple sclerosis - a mitochondria-mediated disease?] / Multippel sklerose en mitokondriemediert sykdom?
Tidsskr Nor Laegeforen
; 137(4): 284-287, 2017 Feb.
Artigo
Norueguês
| MEDLINE | ID: mdl-28225235
18.
Molecular pathogenesis of polymerase γ-related neurodegeneration.
Ann Neurol
; 76(1): 66-81, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24841123
19.
Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
Brain
; 136(Pt 8): 2393-404, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23625061
20.
No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease.
Brain
; 141(3): e16, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29373637